Mycolog-Ii en es it fr

Mycolog-Ii Brand names, Mycolog-Ii Analogs

Mycolog-Ii Brand Names Mixture

  • No information avaliable

Mycolog-Ii Chemical_Formula


Mycolog-Ii RX_link

Mycolog-Ii fda sheet

Mycolog-Ii FDA

Mycolog-Ii msds (material safety sheet)

Mycolog-Ii MSDS

Mycolog-Ii Synthesis Reference

No information avaliable

Mycolog-Ii Molecular Weight

926.09 g/mol

Mycolog-Ii Melting Point


Mycolog-Ii H2O Solubility

360 mg/L

Mycolog-Ii State


Mycolog-Ii LogP


Mycolog-Ii Dosage Forms

Cream; Drops; Liquid; Ointment; Suspension; Tablet

Mycolog-Ii Indication

For treatment of cutaneous or mucocutaneous mycotic infections caused by Candida species

Mycolog-Ii Pharmacology

Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

Mycolog-Ii Absorption

Nystatin is not absorbed from intact skin or mucous membrane

Mycolog-Ii side effects and Toxicity

No information avaliable

Mycolog-Ii Patient Information

No information avaliable

Mycolog-Ii Organisms Affected